ResMed Inc. (RMD) Stock Price Today
Aura AI Summary
Key Stats
- $34.00BMarket Cap
- -Volume
- HealthSector
- $283.2852W High
- $182.8252W Low
- -Typical Hold Time
- $33.36BEnterprise Value
- 1.12%Div Yield
- -Trading Activity
Track ResMed Inc. (RMD) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, ResMed Inc. has traded between a low of $182.82 and a high of $283.28, highlighting its annual price range. Buy and sell ResMed Inc. shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About ResMed Inc.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Most Recent News
BP shifts assets and invests in Brazil amid mixed analyst ratings.
BP, a major global energy company, is actively managing its portfolio by potentially selling oil and gas assets in Egypt to Energean and investing in new projects like a Halliburton contract in Brazil's offshore field. This strategic move aims to enh...
Investigation launched into Noble Corp for alleged securities fraud after Q2 earnings miss.
Pomerantz LLP is investigating Noble Corporation and some of its executives for potential securities fraud following the company's Q2 2026 financial report. Noble disclosed a $43 million loss due to rig suspensions in Brazil and lowered its full-year...
Investigation launched into Alphabet over AI delays and financial disclosures impacting stock price
Pomerantz LLP is investigating Alphabet Inc. for potential securities fraud related to delays in delivering its AI model Gemini 3.5 Pro and significant financial disclosures. Alphabet's stock dropped notably after reports of delays and disappointing ...
People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.